Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H8WV
|
||||
Former ID |
DNC012678
|
||||
Drug Name |
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Thr(Beta-D-Glc)-Gly-NH2
|
||||
Indication | Discovery agent | Investigative | [534460] | ||
Structure |
Download2D MOL |
||||
Formula |
C49H65N9O16
|
||||
Canonical SMILES |
CC(C(C(=O)NCC(=O)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)<br />NC(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(<br />C=C4)O)N)OC5C(C(C(C(O5)CO)O)O)O
|
||||
InChI |
1S/C49H65N9O16/c1-25(54-44(68)32(50)19-28-10-14-30(60)15-11-28)43(67)56-33(20-27-7-4-3-5-8-27)45(69)53-23-38(63)55-34(21-29-12-16-31(61)17-13-29)48(72)58-18-6-9-35(58)46(70)57-39(47(71)52-22-37(51)62)26(2)73-49-42(66)41(65)40(64)36(24-59)74-49/h3-5,7-8,10-17,25-26,32-36,39-42,49,59-61,64-66H,6,9,18-24,50H2,1-2H3,(H2,51,62)(H,52,71)(H,53,69)(H,54,68)(H,55,63)(H,56,67)(H,57,70)/t25-,26?,32+,33+,34+,35+,36?,39+,40?,41?,42?,49?/m1/s1
|
||||
InChIKey |
ZXTWNLGGKJOAMK-XUDWIOABSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [534460] | |
Delta-type opioid receptor | Target Info | Inhibitor | [534460] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.